Vitamin K [EPC]

6600 reported adverse events

Drugs of this class: PHYTONADIONE ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN-5 PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, FOLIC ACID, BIOTIN, CYANOCOBALAMIN ARNICA MONTANA, CALENDULA OFFICINALIS, CARDUUS MARIANUS, GRAPHITES, HYPERICUM PERFORATUM, STAPHYSAGRIA, THIOSINAMINUM, VITAMIN K1 ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, FOLIC ACID, BIOTIN, CYANOCOBALAMIN VITAMIN K1 - PHYTONADIONE VITAMIN K1, PHYTONADIONE

These side effects are most commonly reported by patients taking drugs of the Vitamin K [EPC] class:

# Side effect Count
0 NAUSEA 447
1 OFF LABEL USE 380
2 FATIGUE 370
3 VOMITING 361
4 DYSPNOEA 330
5 DIARRHOEA 328
6 SEPSIS 292
7 ABDOMINAL PAIN 277
8 PYREXIA 265
9 CONSTIPATION 253
See all common reactions for Vitamin K [EPC]

Drugs of the Vitamin K [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 119 0.7628
1 HAEMORRHAGE NEONATAL 6 0.1333
2 HYPER IGE SYNDROME 11 0.1236
3 CYSTIC FIBROSIS RELATED DIABETES 7 0.0787
4 FACTOR V INHIBITION 10 0.0571
5 VITAMIN K DEFICIENCY 15 0.0514
6 RENAL VASCULAR THROMBOSIS 6 0.0484
7 TERMINAL ILEITIS 8 0.0476
8 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 218 0.0464
9 DISTAL INTESTINAL OBSTRUCTION SYNDROME 10 0.0452
See all enriched reactions for Vitamin K [EPC]